2024 Q1 Form 10-Q Financial Statement

#000162828024024396 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $220.0K $4.562M
YoY Change -92.91% -13.68%
Cost Of Revenue $79.00K $1.458M
YoY Change -90.01% 0.41%
Gross Profit $141.0K $3.104M
YoY Change -93.9% -19.02%
Gross Profit Margin 64.09% 68.04%
Selling, General & Admin $2.021M $17.61M
YoY Change -69.96% 75.59%
% of Gross Profit 1433.33% 567.2%
Research & Development $464.0K $4.355M
YoY Change -76.6% 8.36%
% of Gross Profit 329.08% 140.3%
Depreciation & Amortization $56.00K $387.0K
YoY Change -96.15% -79.51%
% of Gross Profit 39.72% 12.47%
Operating Expenses $9.018M $22.80M
YoY Change -14.07% 48.07%
Operating Profit -$8.877M -$19.70M
YoY Change 8.49% 70.3%
Interest Expense $13.00M -$4.730M
YoY Change -868.89% 48.32%
% of Operating Profit
Other Income/Expense, Net $6.279M -$2.667M
YoY Change -477.8% -189.83%
Pretax Income -$2.598M -$34.33M
YoY Change -73.61% 107.12%
Income Tax $4.000K $24.00K
% Of Pretax Income
Net Earnings -$2.602M -$45.95M
YoY Change -84.58% 212.14%
Net Earnings / Revenue -1182.73% -1007.17%
Basic Earnings Per Share -$0.50
Diluted Earnings Per Share -$0.50 -$76.42
COMMON SHARES
Basic Shares Outstanding 5.367M shares 127.7M shares
Diluted Shares Outstanding 5.367M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.801M $6.254M
YoY Change -88.19% -69.09%
Cash & Equivalents $1.801M $6.254M
Short-Term Investments
Other Short-Term Assets $2.170M $5.056M
YoY Change -22.42% 46.42%
Inventory $2.875M $2.415M
Prepaid Expenses
Receivables $797.0K $568.0K
Other Receivables $642.0K $61.00K
Total Short-Term Assets $11.55M $20.50M
YoY Change -51.19% -31.36%
LONG-TERM ASSETS
Property, Plant & Equipment $250.0K $277.0K
YoY Change -76.24% -88.82%
Goodwill $12.40M $0.00
YoY Change
Intangibles $5.018M $2.208M
YoY Change 78.58% -90.09%
Long-Term Investments $100.0K
YoY Change -90.44%
Other Assets $914.0K $145.0K
YoY Change 422.29% -30.95%
Total Long-Term Assets $19.23M $3.270M
YoY Change 207.83% -88.22%
TOTAL ASSETS
Total Short-Term Assets $11.55M $20.50M
Total Long-Term Assets $19.23M $3.270M
Total Assets $30.78M $23.77M
YoY Change 2.93% -58.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.948M $2.449M
YoY Change 293.21% -4.22%
Accrued Expenses $4.905M $2.007M
YoY Change -4.05% -58.46%
Deferred Revenue $807.0K $600.0K
YoY Change 20.0%
Short-Term Debt $838.0K $8.738M
YoY Change -94.4% -35.95%
Long-Term Debt Due $838.0K $8.738M
YoY Change -94.4% -35.95%
Total Short-Term Liabilities $16.65M $16.90M
YoY Change -28.95% -31.62%
LONG-TERM LIABILITIES
Long-Term Debt $65.00K $18.55M
YoY Change
Other Long-Term Liabilities $0.00 $333.0K
YoY Change -100.0% -58.68%
Total Long-Term Liabilities $65.00K $18.88M
YoY Change -78.11% 2242.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.65M $16.90M
Total Long-Term Liabilities $65.00K $18.88M
Total Liabilities $17.12M $17.04M
YoY Change -27.86% -33.01%
SHAREHOLDERS EQUITY
Retained Earnings -$60.56M -$359.7M
YoY Change -81.68% 14.25%
Common Stock $10.00K $3.000K
YoY Change -37.5% -25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.67M $6.339M
YoY Change
Total Liabilities & Shareholders Equity $30.78M $23.77M
YoY Change 2.93% -58.76%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$2.602M -$45.95M
YoY Change -84.58% 212.14%
Depreciation, Depletion And Amortization $56.00K $387.0K
YoY Change -96.15% -79.51%
Cash From Operating Activities -$2.600M -$4.123M
YoY Change -72.63% -41.27%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $80.00K
YoY Change 16.67% -77.84%
Acquisitions
YoY Change
Other Investing Activities $2.968M -$3.978M
YoY Change -2078.67%
Cash From Investing Activities $2.958M -$4.058M
YoY Change -886.7% 1024.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.390M 2.023M
YoY Change -71.59% -105.7%
NET CHANGE
Cash From Operating Activities -$2.600M -4.123M
Cash From Investing Activities $2.958M -4.058M
Cash From Financing Activities $1.390M 2.023M
Net Change In Cash $1.796M -6.158M
YoY Change -136.06% -85.64%
FREE CASH FLOW
Cash From Operating Activities -$2.600M -$4.123M
Capital Expenditures $7.000K $80.00K
Free Cash Flow -$2.607M -$4.203M
YoY Change -72.58% -43.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9919411 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9919411 shares
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
79000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
141000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
464000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
435000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
304000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
135000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1717000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
570000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6490000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
137000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
9018000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1284000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8877000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1284000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-261000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-233000 usd
CY2024Q1 inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
17000 usd
CY2023Q1 inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
22000 usd
CY2024Q1 inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
6732000 usd
CY2023Q1 inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
0 usd
CY2024Q1 inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
12882000 usd
CY2023Q1 inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
0 usd
CY2024Q1 inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
0 usd
CY2023Q1 inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
26000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-398000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6279000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-281000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2598000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1565000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2602000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1565000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
61000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2663000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1565000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5366823 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5366823 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3790106 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3790106 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2663000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1565000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-166000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2829000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1565000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31629000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8691000 usd
CY2024Q1 inpx Stock Issued During Period Value Inducement Loss On Debt Conversions
StockIssuedDuringPeriodValueInducementLossOnDebtConversions
6732000 usd
CY2024Q1 inpx Stock Issued During Period Value Issued For Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueIssuedForCashlessExerciseOfWarrants
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
25605000 usd
CY2024Q1 inpx Adjustments To Additional Paid In Capital Forgiveness Of Related Party Payable
AdjustmentsToAdditionalPaidInCapitalForgivenessOfRelatedPartyPayable
380000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5792000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-166000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
61000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2602000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
13665000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14982000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
141000 usd
CY2023Q1 inpx Adjustments To Additional Paid In Capital Warrants Issued With Convertible Note
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedWithConvertibleNote
39000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1565000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-16367000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2602000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1565000 usd
CY2024Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
13000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3000 usd
CY2024Q1 inpx Amortization Of Intangible Assets Including Other Amortization
AmortizationOfIntangibleAssetsIncludingOtherAmortization
43000 usd
CY2023Q1 inpx Amortization Of Intangible Assets Including Other Amortization
AmortizationOfIntangibleAssetsIncludingOtherAmortization
7000 usd
CY2024Q1 inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
17000 usd
CY2023Q1 inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
22000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5792000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
141000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
77000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
116000 usd
CY2024Q1 inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
0 usd
CY2023Q1 inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
26000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q1 inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
12882000 usd
CY2023Q1 inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
0 usd
CY2024Q1 inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
6732000 usd
CY2023Q1 inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
0 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-398000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2024Q1 inpx Unrealized Gain Loss On Foreign Currency Transactions
UnrealizedGainLossOnForeignCurrencyTransactions
127000 usd
CY2023Q1 inpx Unrealized Gain Loss On Foreign Currency Transactions
UnrealizedGainLossOnForeignCurrencyTransactions
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
143000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-373000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
841000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1722000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
496000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-60000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
29000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-496000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
136000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
243000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
116000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2024Q1 inpx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-8000 usd
CY2023Q1 inpx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2551000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-457000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2968000 usd
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2958000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
378000 usd
CY2023Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
415000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1012000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
300000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1390000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
715000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1796000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
258000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1801000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
373000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 inpx Common Shares Issued For Extinguishment Of Debt
CommonSharesIssuedForExtinguishmentOfDebt
5637000 usd
CY2023Q1 inpx Common Shares Issued For Extinguishment Of Debt
CommonSharesIssuedForExtinguishmentOfDebt
0 usd
CY2024Q1 inpx Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Merger Consideration Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentMergerConsiderationIssued
22637000 usd
CY2023Q1 inpx Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Merger Consideration Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentMergerConsiderationIssued
0 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
394000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 inpx Common Shares Issued For Conversion Of Debt And Accrued Interest
CommonSharesIssuedForConversionOfDebtAndAccruedInterest
3959000 usd
CY2023Q1 inpx Common Shares Issued For Conversion Of Debt And Accrued Interest
CommonSharesIssuedForConversionOfDebtAndAccruedInterest
0 usd
CY2024Q1 inpx Share Based Compensation Arrangement By Share Based Payment Award Shares Issued To Forgiveness Of Related Party Payable
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedToForgivenessOfRelatedPartyPayable
380000 usd
CY2023Q1 inpx Share Based Compensation Arrangement By Share Based Payment Award Shares Issued To Forgiveness Of Related Party Payable
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedToForgivenessOfRelatedPartyPayable
0 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
61000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2024Q1 inpx Working Capital Surplus Deficiency
WorkingCapitalSurplusDeficiency
-5100000 usd
CY2024Q1 us-gaap Cash
Cash
1800000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2700000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2600000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of stock-based compensation;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the valuation of the Company’s common stock issued in transactions, including acquisitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of equity securities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of warrant liabilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of convertible notes, at fair value;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of loan conversion derivatives; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation allowance for deferred tax assets.</span></div>
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 inpx Revenue From Contract With Customer Stated Term
RevenueFromContractWithCustomerStatedTerm
P1Y
CY2024Q1 inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
5153000 usd
CY2023Q1 inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
0 usd
CY2024Q1 inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
5792000 usd
CY2023Q1 inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
141000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2563032 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1694771 shares
CY2024Q1 inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
549286 shares
CY2023Q1 inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
608528 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
236093 shares
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
727000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1292000 usd
CY2024Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-16530000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-9284000 usd
CY2024Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-1.67
CY2024Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-1.67
CY2023Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.94
CY2023Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.94
CY2024Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
9919411 shares
CY2024Q1 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9919411 shares
CY2023Q1 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9919411 shares
CY2023Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
9919411 shares
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5216000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
198000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5018000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
421000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
155000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
266000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000.00 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000.00 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
577000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
851000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
851000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
851000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
770000 usd
CY2024Q1 inpx Finite Lived Intangible Asset Expected Amortization After Year Four And Thereafter
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFourAndThereafter
1118000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5018000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
29000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
125000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2721000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
2875000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2024Q1 inpx Accrued Compensation And Employee Benefits Current
AccruedCompensationAndEmployeeBenefitsCurrent
3218000 usd
CY2023Q4 inpx Accrued Compensation And Employee Benefits Current
AccruedCompensationAndEmployeeBenefitsCurrent
649000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
613000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
173000 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
518000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
305000 usd
CY2024Q1 inpx Accrued Consulting Agreements Expense Current
AccruedConsultingAgreementsExpenseCurrent
302000 usd
CY2023Q4 inpx Accrued Consulting Agreements Expense Current
AccruedConsultingAgreementsExpenseCurrent
0 usd
CY2024Q1 inpx Accrued Due To Grafiti Group Llc Current
AccruedDueToGrafitiGroupLLCCurrent
254000 usd
CY2023Q4 inpx Accrued Due To Grafiti Group Llc Current
AccruedDueToGrafitiGroupLLCCurrent
0 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4905000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1127000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
50000 usd
CY2024Q1 inpx Debt Instrument Unamortized Loan Costs Current
DebtInstrumentUnamortizedLoanCostsCurrent
0 usd
CY2023Q4 inpx Debt Instrument Unamortized Loan Costs Current
DebtInstrumentUnamortizedLoanCostsCurrent
35000 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
838000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
6690000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
1210000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
65000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18546000 usd
CY2024Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
400000 usd
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
200000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 inpx Preferred Stock Annual Rate Of Return
PreferredStockAnnualRateOfReturn
0.10
CY2024Q1 inpx Share Based Compensation Arrangement By Share Based Payment Award Number Of Incentive Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfIncentivePlans
3 incentive_plan
CY2024Q1 inpx Share Based Compensation Options Grant Exercise Price Limit Of Fair Value
ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue
1
CY2024Q1 inpx Share Based Compensation Options Grant Exercise Price Limit Of Fair Value10 Percent Owner
ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue10PercentOwner
1.10
CY2024Q1 inpx Aggregate Number Of Shares Available For Future Grant Under Stock Option Plan
AggregateNumberOfSharesAvailableForFutureGrantUnderStockOptionPlan
62162899 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1161687 shares
CY2024Q1 inpx Share Based Compensation Arrangement By Share Based Payment Award Options Stock Options From Merger In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStockOptionsFromMergerInPeriodGross
1148 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
92728 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
180 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1069927 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000.000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8877000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1284000 usd
CY2024Q1 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
3264000 usd
CY2024Q1 inpx Warrant Fair Value Disclosure
WarrantFairValueDisclosure
448000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3712000 usd
CY2024Q1 inpx Warrant Liability Fair Value Disclosure
WarrantLiabilityFairValueDisclosure
1019000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1019000 usd
CY2023Q4 inpx Warrant Liability Fair Value Disclosure
WarrantLiabilityFairValueDisclosure
497000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
16804000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
333000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17634000 usd
CY2024Q1 us-gaap Revenues
Revenues
220000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8877000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-2602000 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1284000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1565000 usd
CY2024Q1 us-gaap Assets
Assets
30782000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
5921000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
12398000 usd
CY2023Q4 us-gaap Assets
Assets
509000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
278000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
0 usd
CY2024Q1 inpx Operating Lease Accumulated Amortization
OperatingLeaseAccumulatedAmortization
28000 usd
CY2023Q4 inpx Operating Lease Accumulated Amortization
OperatingLeaseAccumulatedAmortization
0 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
653000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
43000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
663000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
259000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
404000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
237000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
220000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
159000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
124000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10000 usd
CY2024Q1 inpx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
750000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
87000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
663000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2023Q4 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
3000000 usd
CY2024Q1 inpx Financing Receivable And Warrant Asset
FinancingReceivableAndWarrantAsset
3700000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3300000 usd
CY2024Q1 inpx Warrant Asset Current
WarrantAssetCurrent
400000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-024396-index-headers.html Edgar Link pending
0001628280-24-024396-index.html Edgar Link pending
0001628280-24-024396.txt Edgar Link pending
0001628280-24-024396-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inpx-20240331.htm Edgar Link pending
inpx-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
inpx-20240331_def.xml Edgar Link unprocessable
inpx-20240331_lab.xml Edgar Link unprocessable
inpx-20240331_pre.xml Edgar Link unprocessable
inpx-20240331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xti10q-2024q1xex311sp.htm Edgar Link pending
xti10q-2024q1xex312bm.htm Edgar Link pending
xti10q-2024q1xex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inpx-20240331_cal.xml Edgar Link unprocessable